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xercise Training and Cardiac
esynchronization Therapy in Heart Failure*
tanley A. Rubin, MD
os Angeles, California
Remix culture” is a term employed by Lawrence Lessig and
ther copyright activists to describe a society that allows and
ncourages derivative works. Lessig presents this as a
esirable ideal and argues, among other things, that the
ealth, progress, and wealth creation of a culture is funda-
entally tied to this participatory remix process (1). The
orrowing, adaptation, and extension of ideas are major
orces that drive creativity and lead to improvement in
ealth care, including treatment of cardiovascular disease.
or example, exercise training (ExT), also known as “reha-
ilitation,” recently extended from the conventional indica-
ion, post-myocardial infarction, to the less-conventional
ndication, systolic dysfunction heart failure, as summarized
y Rubin (2). Enter “remix”: ExT of heart failure patients
ho receive a cardiac resynchronization therapy (CRT)
biventricular pacing) device.
See page 2332
xT in Heart Failure Promotes Clinical Benefit
revious reviews and meta-analyses have demonstrated a
lethora of beneficial effects of ExT in patients who have
ystolic dysfunction heart failure. Summarized, for example,
n a Cochrane review, ExT resulted in modest increases of
eak exercise oxygen uptake (VO2) (peak VO2 range: 10%
o 30% increase), duration of exercise, work capacity, and
istance on the 6-min walk test. Improvements in peak VO2
ere greater in training programs of greater intensity and
uration. Furthermore, health-related quality of life im-
roved in patients in trials that measured this outcome in a
eart failure questionnaire instrument (3). On the basis of
vailable evidence, first an American College of Cardiology/
merican Heart Association (ACC/AHA) guideline state-
ent update recommended ExT in patients with heart
ailure (4). Subsequently, a formalized recognition of this
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.f
From the Department of Veteran Affairs, Greater Los Angeles, and the Depart-
ent of Medicine, Geffen School of Medicine at UCLA, Los Angeles, California.ecommendation appeared as part of the current ACC/
HA guidelines for patients with current or prior symp-
oms of heart failure with reduced systolic function: ExT is
Class I recommendation (Level of Evidence: B) (5).
ecently published in the Journal, a meta-analysis that
xamined the type of exercise found beneficial ventricular
emodeling (negative remodeling) and increased ejection
raction in aerobic (endurance) but not in isometric
strength) ExT programs (6).
Hard” End Points
ight Elude ExT in Heart Failure
owever, other major benefits of this training, including
mproved survival and decreased hospital stay, are less clear.
consortium of European investigators reported improved
urvival in a collaborative meta-analysis that examined death
rom all causes in ExT trials of heart failure. In these
ndurance training trials, exercise significantly reduced both
ortality and death plus hospital admission (7). However, a
ecently concluded, large, multicenter National Institutes of
ealth-sponsored trial of ExT in heart failure, HF-
CTION (Heart Failure: A Controlled Trial Investigating
utcomes of Exercise Training), recently reported a
ailure to achieve the primary end point of improved
urvival and decreased hospital stay (8). We await pub-
ication of substudies and additional outcomes from this
omprehensive trial.
xT Provides Additional
enefit in Patients Receiving CRT
previously published pilot trial of a small number of
atients suggested that functional capacity further improved
y addition of ExT to CRT device implant (9). The study
y Patwala et al. (10) reported in this issue of the Journal
xtends that pilot study in 50 randomized patients with
easurements not only of functional capacity but also
uality of life. After a waiting period of 3 months after
evice implantation, so as to establish a new baseline to
llow effect/benefit of CRT, the methods of the study
ncluded patient randomization to conventional therapy or a
ypical supervised training program during a subsequent
-month period, while maintaining medical therapy. The
uthors report that, as previously demonstrated, CRT alone
roved beneficial in functional capacity (peak VO2) as well
s improved quality of life. Furthermore, adding ExT
aused further improvement in both of these measures as
ell as New York Heart Association functional class when
ompared with the conventional therapy group. Therefore,
he new information provided in this article is that ExT
dded further benefit to exercise capacity and functional
lass, and yielded improved scores on a validated heart
ailure questionnaire.
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n a previous editorial in the Journal, I provided an outline
f heart failure patients who are likely to benefit from ExT
2). Here, I update my thoughts on the issue with the
urrent results in mind.
. Is the concept of ExT added to CRT device implant now
proved? From the standpoint of functional improvement
and quality of life, I would say a qualified “yes.” A larger
trial will likely reinforce that conclusion and, perhaps,
tackle the elusive prize of increased survival and de-
creased hospital stay. In further studies, optimal medical
therapy, including beta- and renin-angiotensin-aldosterone
blockers, needs to find its way to a higher percentage of
patients than the approximately 60% reported in the current
study.
. Is the “juice” worth the “squeeze?” Probably “yes.” The
benefits of ExT largely resolve to a small increase in
functional capacity and quality of life, perhaps a 20%
increase in functional capacity, or, in a measurement
perhaps more easily assimilated by a clinician, approxi-
mately 1 metabolic equivalent. That is enough to permit
patients to do a bit more in their lives. Although this and
other measures of improved “soft” end points are, per-
haps, not as meaningful as improved “hard” end points of
increased survival and reduced hospital stays, most pa-
tients and physicians would welcome the benefit af-
forded. The risk, at least when performed in a supervised
environment as employed in virtually all studies of ExT
in heart failure, is minimal.
. Is every patient eligible for this form of therapy? Eligi-
bility: “yes.” Advisability: “no.” Among the systolic dys-
function heart failure population, patients who have
significant aortic stenosis are precluded. Concomitant
illness that impairs locomotion and the movement of
large muscle groups also prohibits training. Training also
involves patient effort and health care resources, both of
which depend on the patient and his or her health
insurance. The former requires effort and motivation,
whereas the latter requires money. In general, in the
U.S., health care insurance and Medicare will not pay for
this type of rehabilitation. So, the financial burden on the
patient who engages in this might be considerable.
. What are the indications/contraindications/types of
exercise programs? In a previous editorial in the
Journal, I provided some advice and a summary table
to assist the clinician in screening and selecting
appropriate patients as well as the type of exercise
program employed (2). Screening should demonstrate
a heart failure patient who is clinically stable and
medically optimized. The type of training should
emphasize endurance (also called “aerobic” or “dy-
namic” exercise) with a modicum of strength (“isomet-
ric”) training added to the program.emix Redux
uture application of ExT in heart failure should explore
ssues of venue, duration of training, and type/
athophysiology of heart failure. With respect to venue,
ost studies employed ExT in a supervised health care
nvironment. Although initial patient screening and
nstruction should be performed in this environment, it
ill be important to see whether this can be moved to an
nsupervised environment. This is particularly important
ith respect to the duration of training. Extrapolating
rom training studies in typical subjects, functional ben-
fit begins to erode when the training stops. Under the
ubric of “use it or lose it,” it is likely that ExT needs to
e continued indefinitely to afford the patient continued
enefit. It is important to determine the feasibility,
afety, and ultimately the long-term benefit of such a
rogram. With respect to pathophysiology, the unsolved
iddle of the management of heart failure with normal
ystolic function (so-called “diastolic dysfunction”) con-
inues to defy tractability. Given the broad cardiovascular
ffects of ExT and the exasperating lack of effective
reatments for this group of patients, it is not unreason-
ble to propose such a trial. But, even if it cannot be
biquitously applied, ExT continues to demonstrate value
s a “remix” in an ever-increasing group of heart failure
anagement strategies.
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